Menu
Currency
GWAS Study

GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia.

Pasman JA, Verweij KJH, Gerring Z et al.

30150663 PubMed ID
GWAS Study Type
184756 Participants
132 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

PJ
Pasman JA
VK
Verweij KJH
GZ
Gerring Z
SS
Stringer S
SS
Sanchez-Roige S
TJ
Treur JL
AA
Abdellaoui A
NM
Nivard MG
BB
Baselmans BML
OJ
Ong JS
IH
Ip HF
VD
van der Zee MD
BM
Bartels M
DF
Day FR
FP
Fontanillas P
ES
Elson SL
DW
de Wit H
DL
Davis LK
MJ
MacKillop J
DJ
Derringer JL
BS
Branje SJT
HC
Hartman CA
HA
Heath AC
VL
van Lier PAC
MP
Madden PAF
MR
Mägi R
MW
Meeus W
MG
Montgomery GW
OA
Oldehinkel AJ
PZ
Pausova Z
RJ
Ramos-Quiroga JA
PT
Paus T
RM
Ribases M
KJ
Kaprio J
BM
Boks MPM
BJ
Bell JT
ST
Spector TD
GJ
Gelernter J
BD
Boomsma DI
MN
Martin NG
MS
MacGregor S
PJ
Perry JRB
PA
Palmer AA
PD
Posthuma D
MM
Munafò MR
GN
Gillespie NA
DE
Derks EM
VJ
Vink JM
Chapter II

Abstract

Summary of the research findings

Cannabis use is a heritable trait that has been associated with adverse mental health outcomes. In the largest genome-wide association study (GWAS) for lifetime cannabis use to date (N = 184,765), we identified eight genome-wide significant independent single nucleotide polymorphisms in six regions. All measured genetic variants combined explained 11% of the variance. Gene-based tests revealed 35 significant genes in 16 regions, and S-PrediXcan analyses showed that 21 genes had different expression levels for cannabis users versus nonusers. The strongest finding across the different analyses was CADM2, which has been associated with substance use and risk-taking. Significant genetic correlations were found with 14 of 25 tested substance use and mental health-related traits, including smoking, alcohol use, schizophrenia and risk-taking. Mendelian randomization analysis showed evidence for a causal positive influence of schizophrenia risk on cannabis use. Overall, our study provides new insights into the etiology of cannabis use and its relation with mental health.

184,765 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

184756
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Canada, U.S., Australia
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.